Generation platinum chromium coronary stent assort USFDA/DGCI approved Everolimus drug eluting third
Indian Air Force · Kanpur City · Medical Equipment & Supplies · open
Key facts
- Closing date: 22 Jun 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of generation platinum chromium coronary stent assort, USFDA/DGCI approved Everolimus drug eluting third, quantity 2 units, for Indian Air Force under Ministry of Defence, Department of Military Affairs. Bid validity is 180 days from bid end date, with technical and financial evaluation criteria specified.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Certifications: USFDA, DGCI
- Documents required: Relevant contracts, Delivery acceptance certificates, CRAC
Commercial terms
- Bid type: Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- Generation platinum chromium coronary stent assort — Qty: 2 unit
1 tender document(s) available — sign up to download.